Justin Skoble

Vice President, Technical Operations Caribou Biosciences

Justin Skoble is Vice President of Technical Operations at Caribou Biosciences, Inc., where he leads technical operations supporting the development and translation of immunotherapies for cancer and infectious diseases. He is a leader in the area of drug development focused on the research, development, and translation of immunotherapies to treat cancers and prevent infectious diseases. Justin holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley and completed postdoctoral training in Microbiology and Immunology at the University of California, San Francisco.

Seminars

Wednesday 16th September 2026
Scaling Cell Therapies to Enable Large Scale Manufacturing & Market Readiness
12:10 pm
  • Leveraging bioreactors to achieve commercial scale
  • Comparing with alternative scale-up methods to identify trade-offs in efficiency, control and product quality
  • Analyzing cell phenotype post-scale-up to understand the impact of use on product quality
Wednesday 16th September 2026
Panel Discussion: Designing Commercial Manufacturing for Speed or Scale & the Regulatory Trade-Offs
3:00 pm
  • Debating whether commercial manufacturing should prioritize commercial scalability from day one or focus on the fastest path into the clinic, and how each choice shapes regulatory strategy
  • Examining how early process design and analytical development decisions impact potential CMC approval for commercial studies
Justin Skoble - Caribou Bio - Expert Speaker at the 11th CAR-TCR Summit 2026